Roche/Spark Acquisition: First Gene Therapy Deal Clears FTC With No Divestiture

 
• By Brenda Sandburg
  
WASHINGTON, DC - SEPTEMBER 28, 2013: Federal Trade Commission Building in Washington, DC.
FTC finds no antiturst issues in Roche's proposed acquisition of Spark Therapeutics
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies